Study of Subcutaneously Administered Peginesatide in Anemic Cancer Patients Receiving Chemotherapy
Status:
Completed
Trial end date:
2007-06-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to evaluate the safety, pharmacodynamics (PD), and
pharmacokinetics (PK) of multiple subcutaneously administered injections of peginesatide in
anemic cancer participants receiving chemotherapy.